Geographic Access as a Barrier to Adjuvant Chemotherapy for Patients with Stage III Colon Cancer
b'This podcast summarizes new evidence about the role of travel distance, oncologist density, and insurance in receipt of guideline-based chemotherapy for patients with stage III colon cancer.'